 | Up a level |
Chattillion, EA; Roepke, SK; Moore, R; von Känel, R; Mills, PJ; Ziegler, MG; Patterson, TL; Grant, I; Mausbach, BT (2010). Further validation of the pleasant events (PE) and activity restriction (AR) PEAR model of negative outcomes in Alzheimer caregivers: associations with markers of sympathetic tone. Psychosomatic medicine, 2010(72), A71-2. Baltimore, Md.: Lippincott Williams & Wilkins
Marre, M; Shaw, J; Brändle, M; Bebakar, WM; Kamaruddin, NA; Strand, J; Zdravkovic, M; Le, Thi TD; Colagiuri, S; De Loredo, L; Waitman, J; Litwak, L; Rodriguez, M; Vines, G; Maffei, L; Issa, C; Lowy, A; Bartley, P; Kamp, M; Shaw, J; ... (2009). Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU). Diabetic medicine, 2009(26(3)), pp. 268-78. Chichester: Wiley 10.1111/j.1464-5491.2009.02666.x
